Depending on tumor type and conditions, Th17 cells may drive chronic inflammation, which is associated with several tumor types, or enhance the recruitment of CD8+ T cells, neutrophils, and natural killer (NK) cells to the tumor and activate tumor killing [15]. This evidence concerns the gene CD8A and neoplasm.